Matthew Paul Kowalsky insider trades

Open-market stock purchases and sales by Matthew Paul Kowalsky, Chief Legal Officer at Enanta Pharmaceuticals Inc, from SEC Form 4 filings since Jun 30, 2017.

Recent trades

DateStockTradeValue
Feb 12, 2026ENTA Enanta Pharmaceuticals IncBought (not open market)—
Feb 12, 2026ENTA Enanta Pharmaceuticals IncBought (not open market)—
Feb 12, 2026ENTA Enanta Pharmaceuticals IncSold (not open market)$27.1K
Nov 25, 2025ENTA Enanta Pharmaceuticals IncBought (not open market)—

Companies traded

  • ENTA Enanta Pharmaceuticals Inc: other filings, last Feb 12, 2026
  • SGTX Sigilon Therapeutics, Inc: other filings, last Aug 11, 2023
  • PRTO Proteon Therapeutics Inc: other filings, last Jun 29, 2018

Get free alerts when Matthew Paul Kowalsky files a new trade →